Vaccinia Immune Globulin (VIG) from Japan
VIG is human immune serum globulin rich in antibodies against vaccinia virus, used to manage complications from smallpox vaccination. Under HTS 3002.12.0030 as human immune blood sera from donors vaccinated with vaccinia. It provides passive immunity via intravenous or intramuscular injection.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include CDC emergency use authorization if applicable; standard FDA import alert 81-01 applies
• Validate heat-treated formulation docs to prove viral safety per FDA CBER guidelines